The MC38 colon adenocarcinoma syngeneic model on a C57BL/6 background is highly immunogenic and it has been demonstrated to be sensitive to anti-PD-L1 immune checkpoint monotherapy [41,42]. This evidence concerns the gene CD274 and colon adenocarcinoma.